Edition:
United Kingdom

People: Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

0.63USD
7:34pm BST
Change (% chg)

$-0.01 (-0.83%)
Prev Close
$0.64
Open
$0.62
Day's High
$0.65
Day's Low
$0.62
Volume
25,647
Avg. Vol
33,625
52-wk High
$1.32
52-wk Low
$0.55

Tenenbaum, Fabian 

Mr. Fabian Tenenbaum serves as Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Director of the Company. Mr. Tenenbaum has served as Chief Financial Officer and Chief Business Officer of the Company since February 29, 2016. Prior to joining the Company, Mr. Tenenbaum served as Chief Financial Officer and Chief Business Officer of Anterios, Inc., a clinical-stage biopharmaceutical company focused on the development of dermatology products, from 2014 to 2016. Prior to that, Mr. Tenenbaum served as Chief Executive Officer with Syneron Beauty from 2011 to 2014, and Chief Financial Officer and Executive Vice President of Syneron Medical from 2007 to 2011. Prior to Syneron Medical, Mr. Tenenbaum was Vice President Americas for Radiancy, Inc., from 2002 to 2006, and Director, Commercial Operations and Corporate Development at Sunlight Medical, Inc. from 1999 to 2002. Mr. Tenenbaum holds a Bachelor in Medicine (B.Md.) from Ben Gurion University, Israel and an MBA from Columbia Business School.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --